- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
JPMorgan Chase Reduces Stake in Pet Insurer Trupanion
Institutional investor trims position in fast-growing pet insurance provider
Apr. 5, 2026 at 8:43am
Got story updates? Submit your updates here. ›
JPMorgan Chase & Co. has reduced its stake in Trupanion, Inc. (NASDAQ:TRUP), a leading provider of pet medical insurance, by 52% in the third quarter according to a recent SEC filing. The financial services giant now owns approximately 77,649 shares of Trupanion, down from 161,781 shares previously.
Why it matters
Trupanion's stock price has experienced significant volatility in recent quarters as the company continues to rapidly expand its customer base and invest in growth initiatives. JPMorgan's decision to trim its position could signal broader market uncertainty about the pet insurer's near-term prospects, though the company remains a dominant player in the fast-growing pet insurance industry.
The details
According to the SEC filing, JPMorgan Chase sold 84,132 shares of Trupanion stock during the third quarter, reducing its overall stake in the company to just 0.18%. The move comes as Trupanion has faced headwinds including increased competition, rising costs, and a challenging macroeconomic environment that has pressured its share price. However, the company continues to report strong revenue growth and is widely viewed as a leader in the expanding pet insurance market.
- JPMorgan Chase reduced its Trupanion stake in the third quarter of 2026.
- Trupanion's stock price has experienced significant volatility in recent quarters.
The players
JPMorgan Chase & Co.
A major global financial services firm and one of the largest institutional investors in Trupanion.
Trupanion, Inc.
A leading provider of pet medical insurance, headquartered in Seattle, Washington.
What they’re saying
“We must remain cautious about Trupanion's near-term prospects as the company navigates a challenging market environment.”
— Analyst
What’s next
Investors will be closely watching Trupanion's upcoming earnings report and guidance to gauge the company's performance and outlook amid the current market conditions.
The takeaway
JPMorgan Chase's decision to reduce its stake in Trupanion highlights the volatility and uncertainty surrounding the pet insurance provider's short-term prospects, even as the company remains a leader in a rapidly growing industry.
Seattle top stories
Seattle events
Apr. 5, 2026
Nick LoweApr. 5, 2026
Lexa Gates



